Skip to main content

Arcturus Therapeutics Holdings Inc.

ARCT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001768224

No open-market purchases or sales by Arcturus Therapeutics Holdings Inc. insiders were filed in the last 90 days; 135 institutions reported holding it in 13F filings for Q2 2026, worth $167.9M in total; ARK Invest is the only superinvestor holding it.

Q4 2022 vs. Q3 2022

How the institutions holding Arcturus Therapeutics Holdings Inc. changed between Q3 2022 and Q4 2022.

All holders in Q4 2022All holders in Q3 2022

13F holders of ARCT: Q3 2022 compared with Q4 2022
MeasureQ3 2022Of which not filed for Q4 2022Q4 2022Change
Holders1172113−2
Shares22.2M120.4K22.6M+591.1K (+2.7%)
Value$328.1M$1.78M$383.9M+$57.6M (+17.7%)

2 institutions that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (19)

Institutions that held Arcturus Therapeutics Holdings Inc. at the end of Q4 2022 but not at the end of Q3 2022.

Institutions new to ARCT in Q4 2022
InstitutionSharesValue% of portfolio
HRT Financial LP60,482$1.02M0.01%
Cubist Systematic Strategies, LLC54,865$930.5K0.01%
Pura Vida Investments, LLC50,000$848.0K0.14%
Mackenzie Financial Corp28,612$485.3K0.00%
Trexquant Investment LP21,284$361.0K0.01%
Jump Financial, LLC20,478$347.3K0.02%
Shell Asset Management Co15,855$269.0K0.01%
Aquatic Capital Management LLC13,800$234.0K0.02%
Dynamic Technology Lab Private Ltd12,193$207.0K0.02%
Qube Research & Technologies Ltd11,814$200.4K0.00%
Gsa Capital Partners LLP10,281$174.0K0.02%
Point72 Middle East FZE4,673$79.3K0.01%
Quantbot Technologies LP2,296$38.9K0.00%
Belpointe Asset Management LLC743$12.6K0.00%
Dark Forest Capital Management LP620$10.5K0.00%
Comerica Securities,inc.36$6110.00%
NewSquare Capital LLC4$680.00%
Sofos Investments, Inc.17$320.00%
GWM Advisors LLC26$00.00%

Sold out (21)

Institutions that held Arcturus Therapeutics Holdings Inc. at the end of Q3 2022 and filed for Q4 2022 without it.

Not filed for Q4 2022 yet (2)

Institutions that held Arcturus Therapeutics Holdings Inc. at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding ARCT in Q3 2022 that haven't filed for Q4 2022
InstitutionShares, Q3 2022Value, Q3 2022
ACT Capital Management, LLC120,400$1.78M
Wipfli Financial Advisors LLC,46$1.00K